Los Angeles Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,701
| Closed | -$337K | – | 1114 |
|
|
2023
Q2 | $337K | Buy |
+3,701
| New | +$337K | ﹤0.01% | 962 |
|
|
2022
Q4 | – | Sell |
-4,314
| Closed | -$295K | – | 1185 |
|
|
2022
Q3 | $295K | Buy |
+4,314
| New | +$295K | ﹤0.01% | 1073 |
|
|
2021
Q2 | – | Sell |
-13,611
| Closed | -$584K | – | 1528 |
|
|
2021
Q1 | $584K | Buy |
13,611
+4,806
| +55% | +$206K | ﹤0.01% | 1149 |
|
|
2020
Q4 | $504K | Buy |
8,805
+365
| +4% | +$20.9K | ﹤0.01% | 1204 |
|
|
2020
Q3 | $255K | Buy |
+8,440
| New | +$255K | ﹤0.01% | 1317 |
|